Is WST research on Rallies investment advice?

No. Rallies provides research, data, and educational context for WST. It does not provide personalized investment advice.

WST (West Pharmaceutical Services, Inc.) Stock Analysis - Financials

West Pharmaceutical Services, Inc. (WST) is a publicly traded Healthcare sector company. As of July 22, 2026, WST trades at $359.34 with a market cap of $24.89B and a P/E ratio of 47.79. WST moved +1.96% today. Year to date, WST is +30.57%; over the trailing twelve months it is +71.00%. Its 52-week range spans $187.43 to $367.66. Analyst consensus is strong buy with an average price target of $399.63. Rallies surfaces WST's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are WST's key financials?

WST financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. WST recently traded at $359.34. Market cap is $24.89B. P/E ratio is 47.79. Revenue is $3.22B.

WST Key Metrics

Key financial metrics for WST
Metric	Value
Price	$359.34
Market Cap	$24.89B
P/E Ratio	47.79
EPS	$7.52
Dividend Yield	0.22%
52-Week High	$367.66
52-Week Low	$187.43
Volume	464.70K
Avg Volume	0
Revenue (TTM)	$3.22B
Net Income	$542.70M
Gross Margin	36.28%

WST Analyst Consensus

10 analysts cover WST: 0 strong buy, 9 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $399.63.

Common questions about WST

What are WST's key financials?: WST financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. WST recently traded at $359.34. Market cap is $24.89B. P/E ratio is 47.79. Revenue is $3.22B.
Is WST research on Rallies investment advice?: No. Rallies provides research, data, and educational context for WST. It does not provide personalized investment advice.